Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 8,120 | 7,803 | 6,567 | 7,531 | 6,084 |
| Cost of Goods | 3,759 | 3,957 | 3,430 | 3,696 | 3,169 |
| Gross Profit | 4,361 | 3,846 | 3,137 | 3,835 | 2,915 |
| Operating Expenses | 13,716 | 12,740 | 11,966 | 13,309 | 6,260 |
| Operating Income | -8,596 | -7,937 | -8,399 | -8,778 | -3,176 |
| Interest Expense | 9 | 48 | 44 | 44 | 45 |
| Other Income | 0 | -65 | 0 | 0 | 0 |
| Pre-tax Income | -8,605 | -8,050 | -8,443 | -8,822 | -3,221 |
| Net Income Continuous | -8,605 | -8,050 | -8,443 | -8,822 | -3,221 |
| Net Income Discontinuous | N/A | N/A | N/A | 0 | 5,358 |
| Net Income | $-8,605 | $-8,050 | $-8,443 | $-8,822 | $2,137 |
| EPS Basic Total Ops | -0.16 | -0.15 | -0.15 | -0.19 | 0.05 |
| EPS Basic Continuous Ops | -0.16 | -0.15 | -0.15 | -0.19 | -0.07 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.00 | 0.12 |
| EPS Diluted Total Ops | -0.16 | -0.15 | -0.15 | -0.18 | 0.04 |
| EPS Diluted Continuous Ops | -0.16 | -0.15 | -0.15 | -0.19 | -0.07 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.01 | 0.11 |
| EBITDA(a) | $-8,368 | $-7,733 | $-8,220 | $-8,606 | $-2,986 |